|
|
News Breaks | | | | August 13, 2012 | | 05:06 EDT |  | TARO | Sun Pharmaceutical to take Taro Pharmaceutical private
Sun Pharmaceutical Industries and Taro Pharmaceutical Industries announced that they have entered into a merger agreement together with certain affiliates of Sun Pharma. The merger agreement provides that all shareholders of Taro other than Sun Pharma and its affiliates will receive a cash payment of $39.50 per share upon the closing of the merger. Sun Pharma and its affiliates collectively own approximately 66.0% of the outstanding Taro ordinary shares and 100% of Taro’s founders shares, representing approximately 77.5% of the outstanding voting power in Taro. Upon completion of the merger, Taro will become a privately held company, will be wholly owned by affiliates of Sun Pharma, and its ordinary shares will no longer be traded on the NYSE. The merger agreement was approved by Taro’s Board of Directors based upon the recommendations and approvals of the Special Committee and the Audit Committee of Taro’s Board of Directors. | |
|
News For TARO From The Last 14 Days Check below for free stories on TARO the last two weeks. |
|
|
| There are no results for TARO |
|
|
|
|
|
|
